Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-Effectiveness
GBI Research, the leading business intelligence provider, has released its latest research, Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness, which provides key data, information and analysis of the Contract Manufacturing Organization (CMO) industry, and the downstream processing and reagent market.
View full press release